Cellectis S.A. (NASDAQ: CLLS) today announced the launch, subject to market conditions, of an underwritten public offering of $175 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE